hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646/CDK6 pathway

Table 1 Correlation between hsa_circ_0081143 expression and clinical features of GC patients

Clinicopathological features	Total	hsa_circ_0081143		P
Clinicopathological features	Total	Low	High	P
Age (years)				0.464
< 60	14	6	8
≥ 60	16	9	7
Gender				0.273
Male	15	9	6
Female	15	6	9
Tumor size (cm)				0.269
< 5	17	10	7
≥ 5	13	5	8
Differentiation				0.058
Well	11	8	3
Moderate + poor	19	7	12
TNM stage				0.025
I + II	12	9	3
III + IV	18	6	12
Lymph node metastasis				0.008
No	19	13	6
Yes	11	2	9

ISSN: 1475-2867